Full Press Release Details
Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer
YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) - Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company,
has appointed digital marketing expert and industry thought-leader, Bryant Hussey, to the new position of chief digital officer.
He will lead the company's marketing and customer retention efforts, as well as help launch new or enhanced telemedicine
products, improve unit economics, and maximize patient lifetime value.
brings to Conversion Labs more than 20 years of executive experience at direct-to-consumer and eCommerce companies, translating
business goals into successful marketing campaigns. He specializes in lead generation, funnel optimization and customer retention
that maximizes customer lifetime value and lowers cost per acquisition.
previously served as chief digital officer at Advanced Vita Supplements (AVS), a direct response nutraceutical company and an
official global licensee of Playboy Enterprise's sexual wellness supplements. At AVS, he was responsible for creating targeted
campaigns that increased brand awareness and customer conversions, and he led the launch of the company's subscription-based
to AVS, Hussey was vice president of Atlantic Coast Brands, an Inc. 500' omni-channel international beauty company
that has serviced more than 10 million customers worldwide and generated $1 billion in revenue overall. He led the company's
digital marketing campaigns for its hair regrowth system for women which attracted more than 1 million customers and generated
$500 million in revenue. He also grew Atlantic's subscription-based business, adding 60,000 subscriptions per month on average
advertising that drives subscriptions is key to our growth strategy and building shareholder value, making Bryant's proven
success in this arena a perfect fit for Conversion Labs," stated Conversion Labs CEO, Justin Schreiber. "Bryant has
shown to be especially adept at evaluating the trends in the global consumer markets, and creating online marketing campaigns
that effectively address them.
expect his knowledge and experience to help us fully optimize our digital marketing strategies and extract maximum value from
our growing line of telemedicine products that address large and underserved markets. This includes the near-term launch of a
new brand extension for our popular Rex MD line for men's health that addresses additional medical indications."
Labs recently reported that its annual recurring revenue (ARR) from subscriptions reached $23.0 million, up 517% over last year,
largely due to consumer demand for Rex MD.
in his career, Hussey served as a marketing director for a division of Ardis Health, an international eCommerce company, where
he focused on the digital marketing of direct-to-consumer diet products. He oversaw the company's media distribution channels
and customer acquisition in the U.S. and assisted in product and business development.
couldn't be more excited to join Conversion Labs with so many opportunities for growth in direct-to-consumer telemedicine,"
said Hussey. "Creating and executing digital marketing strategies for products that make a real difference in people's
lives has long been my passion. I believe what I can bring to Conversion Labs will really make a difference, especially when teaming
with the tremendous talent Justin has brought together over the last several months."
received his B.A. in Economics at Saint Peter's University, and completed professional studies programs in Integrated Marketing
at New York University. He is a certified Google Advertising Professional, and regularly speaks at lead generation and performance
marketing events, including LeadsCon and Affiliate Summit.
nine years Hussey has served on the board of trustees for the House of Faith, a non-profit organization dedicated to transitional
housing programs for the homeless.
Conversion LabsConversion Labs, Inc. is a telemedicine company with a portfolio of online direct-to-consumer brands. The company's
brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed
physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit Conversionlabs.com.
Cautions Regarding Forward-Looking StatementsThis news release includes forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things
our plans, strategies and prospects - both business and financial. Although we believe that our plans, intentions and expectations
reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize
these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions.
Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such
as "believe," "expect," "anticipate," "should," "planned," "will,"
"may," "intend," "estimated," and "potential," among others. Important factors
that could cause actual results to differ materially from the forward-looking statements we make in this news release include
market conditions and those set forth in reports or documents that we file from time to time with the United States Securities
and Exchange Commission. All forward-looking statements attributable to Conversion Labs, Inc. or a person acting on its behalf
are expressly qualified in their entirety by this cautionary language.